Most Recent
Real estate data company BCI has slammed US analytics company CoreLogic’s "desperate" objection to a second data set in their data scraping fight, saying it's an attempt to cut off one mode of proving loss.
The High Court has agreed to hear Otsuka's appeal of a decision that revoked its Abilify patent extension, which Otsuka argued would “lead to a groundswell of court proceedings”.
Australian designer Katie Taylor has won her High Court appeal in a fight with pop star Katy Perry over the right to trade mark her name, with the court saying a Full Court ruling in Perry's favour "rewarded the wrongdoers".
Pharmacor wants to amend its defence in AstraZeneca's suit over the Australian drug maker's plans to launch a generic version of diabetes drug Forxiga so that it can argue a patent extension for the drug should not have been granted.
Dairy company Care A2 has failed to block food producer Care Natural’s trade mark, with an IP Australia delegate finding that the word ‘care’ was not enough to render the mark deceptively similar or identical to Care A2's marks.
The gender pay gap remains a sore spot for IP boutiques and one major US-based litigation firm, according to data released by the Workplace Gender Equality Agency.
Human rights and press freedom activists want to intervene in a High Court case over copyright ownership in abattoir footage obtained by trespass, saying the broader public interest might be affected by the case.
The director of a documentary about a US narcotics officer during the 1990s 'war on drugs' has won his copyright suit against the film's producers, with a judge finding his moral rights under the Copyright Act were infringed by their failure to credit him as the director.
Bayer and Teva have lost their challenge to Indian drug maker Cipla’s extension of its patent for an allergy medication, with IP Australia finding a failure to pay renewal fees on time was due to a genuine error.
Litigation funder ILP, which has sought an injunction to stop tech investor CPC from terminating their agreement for failure to pay legal fees in its patent case against Apple, has rejected claims it is "hedging its bets".